dsm-firmenich’s is close to selling its animal nutrition and health (ANH) business, with final bids expected from private equity firms CVC, Apollo and Dutch rival Nutreco, Dutch newspaper Financieele Dagblad reported recently.
Potential buyers have until July 24 to submit binding offers, with dsm-firmenich aiming to finalize the deal this summer, the report said.
Reuters could not immediately verify the report, and dsm-firmenich declined to comment.
The company said last year it was planning to carve out the ANH business by the end of 2025, which would lower its exposure to earnings volatility in the vitamins segment, as it seeks to sharpen its focus on perfumes and flavors.